Migraine
869
101
133
505
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Published Results
206 trials with published results (24%)
Research Maturity
505 completed trials (58% of total)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
4.8%
42 terminated out of 869 trials
92.3%
+5.8% vs benchmark
26%
226 trials in Phase 3/4
41%
206 of 505 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 505 completed trials
Clinical Trials (869)
A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
A Dose-finding Trial With Lu-AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive Treatments
BE WELL With Migraine: Brain Education and WELLness With Migraine
RimegepAnt effectIvenesS and tolErability as Migraine Preventive Treatment
Study of Oral Atogepant Tablets to Assess Change in Disease Activity in Adult Japanese Participants With Episodic Migraine
Effectiveness and Tolerability of Eptinezumab
A Comprehensive Digital Care Program for Migraine Management
A Study to Compare the Blood Levels of Two Dosage Formulations of the Study Medicine in Healthy Adults
A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine
GORE® CARDIOFORM Septal Occluder Migraine Clinical Study
Evaluation of the Migraceutics® Phase-Specific Dietary Supplement Regimen on Quality of Life, Work Productivity, and Biomarkers in Adult Migraineurs: The Migraceutics® START Study
Evaluation of Treatment Satisfaction and Preference for Sumavel DosePro in the Treatment of Migraine
Sequential, Multiple Assignment, Double Randomized Preference, Migraine Behavioral Trial
Safety and Efficacy of Middle Meningeal Artery Embolization for the Treatment of Migraine.
Determining the Utility of a Behavioral Intervention in Chronic Migraine
Family Study of Affective and Anxiety Spectrum Disorders
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
Effect of Transcutaneous Auricular Trigeminal Nerve Stimulation on Migraine
A Dual Intervention in Migraine Treatment: Tens and Exercise